Potential use of non-classical pathways for the transport of macromolecular drugs

Bibliography

• ZANTA MA, BELGUISE-VALLADIER P, BEHR JP: Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc. Natl. Acad. Sci. USA (1999) 96(1):91–96.
   PubMed Web of Science ®Google Scholar
• LUDTKE JJ, ZHANG G, SEBESTYEN MG, WOLFF JA: A nuclear localization signal can enhance both the nuclear transport and expression of 1 kb DNA. J Cell Sci. (1999) 112 (Pt 12):2033–2041.
   PubMed Web of Science ®Google Scholar
• RUBARTELLI A, COZZOLINO F, TALIO M, SITIA R: A novelsecretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J. (1990) 9(5):1503–1510.
   PubMed Web of Science ®Google Scholar
• RUBARTELLI A, SITIA R: Secretion of mammalian proteins that lack a signal sequence. In: Unusual Secretory Pathways: From Bacteria to Man. Kuchler K (Ed.), R.G. Landes Bioscience, Austin, TX, USA (1997):87–114.
   Google Scholar
• •A thorough look at non-classical protein secretion.
   Google Scholar
• FAWELL S, SEERY J, DAIKH Y et al.: Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. USA (1994) 91:664–668.
   PubMed Web of Science ®Google Scholar
• PEREZ F, LLEDO PM, KARAGOGEOS D, VINCENT JD, PROCHIANTZ A, AYALA J: Rab3A and Rab3B carboxy-terminal peptides are both potent and specific inhibi-tors of prolactin release by rat cultured anterior pituitary cells. Mot. Endocrinol. (1994) 8(9):1278–1287.
   Web of Science ®Google Scholar
• ALLINQUANT B, HANTRAYE P, MAILLEUX P, MOYA K, BOUILLOT C, PROCHIANTZ A: Downregulation of amyloid precursor protein inhibits neurite outgrowth in vitro. J. Cell Biol. (1995) 1 2 8 (5):919–927.
   Google Scholar
• ELLIOTT G, O'HARE P: Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell (1997) 88:223–233.
   PubMed Web of Science ®Google Scholar
• ••Initial findings characterising VP22 intercellular transport.
   Google Scholar
• ELLIOTT GD, MEREDITH DM: The herpes simplex virus Type 1 tegument protein VP22 is encoded by gene UIA9. J. Gen. Virol. (1992) 73 (Pt 3):723–726.
   PubMedGoogle Scholar
• LUFT FC: Can VP22 resurrect gene therapy? J. Mot. Med. (1999) 77 (8):575–576.
   PubMed Web of Science ®Google Scholar
• MURPHY AL, MURPHY SJ: Catch VP22: the hitch-hiker's ride to gene therapy? Gene Ther. (1999) 6(1):4–5.
   Google Scholar
• ELLIOTT G, O'REILLY D, O'HARE P: Phosphorylation of the herpes simplex virus Type 1 tegument protein VP22. Virology (1996) 226(0:140–145.
   PubMedGoogle Scholar
• BLAHO JA, MITCHELL C, ROIZMAN B: An amino acid sequence shared by the herpes simplex virus 1 a regulatory proteins O,4,22 and 27 predicts the nucleo-tidylation of the UL21, 111,31, UL47 and UL49 gene products. J Biol. Chem. (1994) 269 (26) :17401–17410.
   PubMedGoogle Scholar
• KNOPF KW, KAERNER HC: Virus-specific basic phosphoproteins associated with herpes simplex virus type a (HSV-1) particles and the chromatin of HSV-1 -infected cells. J Gen. Virol. (1980) 46(2):405–414.
   PubMedGoogle Scholar
• ELLIOTT G, O'HARE P: Herpes simplex virus type 1 tegument protein VP22 induces the stabilization and hyperacetylation of microtubules. J. Vim/. (1998) 72 (8):6448–6455.
   Web of Science ®Google Scholar
• DERER W, EASWARAN HP, KNOPF CW, LEONHARDT H, CARDOSO MC: Direct protein transfer to terminally differentiated muscle cells. J. Mot. Med. (1999) 77 (8):609–613.
   PubMed Web of Science ®Google Scholar
• AINTS A, DILBER MS, SMITH CIE: Intercellular spread of GFP-VP22. J. Gene Med. (1999) 1:275–279.
   PubMed Web of Science ®Google Scholar
• PHELAN A, ELLIOTT G, O'HARE P: Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nature Biotech. (1998) 1 6 (5) :440–443.
   Google Scholar
• WYBRANIETZ WA, PRINZ F, SPEIGEL M et al.: Quantifica-tion of VP22-GFP spread by direct fluorescence in 15 commonly used cell lines. j Gene Med. (1999) 1:265–274.
   PubMed Web of Science ®Google Scholar
• DILBER MS, PHELAN A, AINTS A et al.: Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22. Gene Ther. (1999) 6 (1) :12–21.
   PubMed Web of Science ®Google Scholar
• •In vivo delivery of a VP22-thymidine kinase therapeutic.
   Google Scholar
• STAUBER DJ, DIGABRIELE AD, HENDRICKSON WA: Structural interactions of fibroblast growth factor receptor with its ligands. Proc. Natl. Acad. Sci. USA (1999) 97 (1):49–54.
   Web of Science ®Google Scholar
• MIDDAUGH CR, VOLKIN D, THOMAS K: Acidic and basic fibroblast growth factors. Curr. Opin. Invest. Drugs (1993) 2(9):991–1005.
   Google Scholar
• WERNER S: Keratinocyte growth factor: a unique player in epithelial repair processes. Cytokine Growth Factor Rev. (1998) 9(2):153–165.
   PubMed Web of Science ®Google Scholar
• JACKSON A, FRIEDMAN S, ZHAN X, ENGLEKA KA, FOROUGH R, MACIAG T: Heat shock induces the release of fibroblast growth factor 1 from NIH 3T3 cells. Proc. Nati Acad. Sci. USA (1992) 89:10691–10695.
   PubMed Web of Science ®Google Scholar
• PIOTROWICZ RS, MARTIN JL, DILLMAN W, H, LEVIN EG:The 27-kDa heat shock protein facilitates basic fibroblast growth factor release from endothelial cells. J. Biol. Chem. (1997) 272(10:7042–7047.
   PubMedGoogle Scholar
• TARANTINI F, LAVALLEE T, JACKSON A et al.: Theextravesicular domain of synaptotagrnin-1 is released with the latent fibroblast growth factor-1 homodimer in response to heat shock. J. Biol. Chem. (1998) 273 (35):22209–22216.
   PubMed Web of Science ®Google Scholar
• EDWARDS KLT, KUELTZO LA, FISHER M, MIDDAUGH CR:Effect of a-crystallin and GroELon the aggregation and refolding of acidic fibroblast growth factor. (In Prepara-tion).
   Google Scholar
• VOLKIN DB, MIDDAUGH CR: The characterization, stabilization and formulation of acidic fibroblast growth factor. In: Formulation, Characterization and Stability of Protein Drugs. Pearlman R, Wang YJ, (Eds.), Plenum Press, New York, USA (1996):181–217.
   Google Scholar
• CITORES L, WESCHE J, KOLPAKOVA E, OLSNES S: Uptake and intracellular transport of acidic fibroblast growth factor: evidence for free and cytoskeleton-anchored fibroblast growth factor receptors. Mol. Biol. Cell (1999) 10:3835–3848.
   PubMed Web of Science ®Google Scholar
• LIN Y-Z, YAO S, HAWINGER J: Role of the nuclearlocalization sequence in fibroblast growth factor-1-stimultaed mitogenic pathways. J Biol. Chem. (1996) 271 (10):5305–5308.
   PubMedGoogle Scholar
• CAO Y, EKSTROM M, PETTERSSON R: Characterization of the nuclear translocation of acidic fibroblast growth factor. J Cell Sci. (1993) 104(1):77–87.
   PubMedGoogle Scholar
• ZHAN X, HU X, FRIEDMAN S, MACIAG T: Analysis of endogenous and exogenous nuclear translocation of fibroblast growth factor-1 in NIH 313 cells. Biochem. Biophys. Res. Commun. (1992) i88(3):982–991.
   Google Scholar
• KLEIN S, CARROLL JA, CHEN Y et al.: Biochemicalanalysis of the arginine methylation of high molecular weight fibroblast growth factor-2. j Biol. Chem. (2000) 275 (5):3150–3157.
   PubMed Web of Science ®Google Scholar
• GAWIAK S, PASTAN I, SIEGALL C: Basic fibroblast growth factor-Pseudomonas ex otoxin chimeric proteins; comparison with acidic fibroblast growth factor -Pseudomonas exotoxin. Bioconj. Chem. (1993) 4 (6):483–489.
   PubMed Web of Science ®Google Scholar
• SIEGALL CB, EPSTEIN S, SPEIR E et al.: Cytotoxic activity of chimeric proteins composed of acidic fibroblast growth factor and Pseudomonas exotoxin on a variety of cell types. FASEB J (1991) 5(13):2843–2849.
   PubMed Web of Science ®Google Scholar
• SIEGALL CB, GAWLAK SL, CHACE DF, MERWIN JR, PASTAN I: In vivo activities of acidic fibroblast growth factor-Pseudomonas exotoxin fusion proteins. Bioconj. Chem. (1994) 5(0:77–83.
   PubMedGoogle Scholar
• WIEDLOCHA A, MADSHUS IH, MACH H, MIDDAUGH CR,OLSNES S: Tight folding of acidic fibroblast growth factor prevents its translocation to the cytosol with diphtheria toxin as vector. EMBO J. (1992) 11 (13):4835–4842.
   PubMed Web of Science ®Google Scholar
• •Structural dependence of FGF-1 translocation.
   Google Scholar
• DIKOV MM, REICH MB, DWORKIN L, THOMAS JW, MILLER GG: A functional fibroblast growth factor-1 immunoglobulin fusion protein. J Biol. Chem. (1998) 273(25):15811–15817.
   PubMed Web of Science ®Google Scholar
• JEANG K-T, XIAO H, RICH EA: Multifaceted activities of the HIV-1 transactivator of transcription, Tat. j Biol. Chem. (1999) 274(4028837–28840.
   Google Scholar
• MANN DA, FRANKEL AD: Endocytosis and targeting of exogenous HIV-1 Tat protein. EMBO J. (1991) 10 (7) :1733–1739.
   PubMed Web of Science ®Google Scholar
• FRANKEL AD, PABO CO: Cellular uptake of the Tat protein from human immunodeficiency virus. Cell (1988) 55:1189–1193.
   PubMed Web of Science ®Google Scholar
• VIVES E, BRODIN P, LEBLEU B: A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol. Chem. (1997) 272 (25):16010–16017.
   PubMed Web of Science ®Google Scholar
• SCHWARZE SR, DOWDY SF: In vivo protein transduc-tion: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol. Sci. (2000) 21 (2):45–48.
   PubMed Web of Science ®Google Scholar
• •Current review of Tat-mediated delivery.
   Google Scholar
• ENSOLI B, BUONAGURO L, BARILLARI G et al.: Release,uptake and effects of extracellular human immunode-ficiency virus Type 1 Tat protein on cell growth and viral transactivation. j Vim/ (1993) 67(0:277–287.
   Google Scholar
• HUANG L, FARHOOD H, SERBINA N, TEEPE AG, BARSOUM J: Endosomolytic activity of cationic liposomes enhances the delivery of human immuno-deficiency virus-1 trans-activator protein (TAT) to mammalian cells. Biochem. Biophys. Res. Commun. (1995) 217 (3):761–768.
   PubMed Web of Science ®Google Scholar
• FONG SE, SMANIK P, SMITH MC, JASKUNAS SR: Cationicliposome-mediated uptake of human immunodefi-ciency virus Type 1 Tat protein into cells. j Virol Methods (1997) 66 (1) :149–157.
   PubMed Web of Science ®Google Scholar
• SCHWARZE SR, HO A, VOCERO-AKBANI A, DOWDY SF: In vivo protein transduction: delivery of a biologically active protein into the mouse. Science (1999) 285 (3):1569–1572.
   PubMedGoogle Scholar
• ••In vivo Tat-mediated delivery.
   Google Scholar
• BAYLEY H: Protein therapy-delivery guaranteed [news]. Nature Biotech. (1999) 17 (11):1066–1067.
   PubMed Web of Science ®Google Scholar
• PEREZ F, JOLIOT A, BLOCH-GALLEGO E, ZAHRAOUI A, TRILLER A, PROCHIANTZ A: Antennapedia homeobox as a signal for the cellular internalization and nuclear addressing of a small exogenous peptide. J Cell Sci. (1992) 102 (Pt 017–722.
   Google Scholar
• PROCHIANTZ A: Getting hydrophilic compounds into cells: lessons from homeopeptides. Curr. Opin. Neurobiol. (1996) 6(5):629–634.
   PubMed Web of Science ®Google Scholar
• PROCHIANTZ A: Homeodomain-derived peptides. In and out of the cells. Ann. NY Acad. Sci. (1999) 886:172–179.
   PubMed Web of Science ®Google Scholar
• ••Thorough review of the current applications ofhomeodomain-derived peptides.
   Google Scholar
• DEROSSI D, CALVET S, TREMBLEAU A, BRUNISSEN A, CHASSAING G, PROCHIANTZ A: Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. (1996) 271(3018188–18193. Effects of helicity and mutation on pAntp internalisation.
   Google Scholar
• DEROSSI D, JOLIOT AH, CHASSAING G, PROCHAINTZ A: The third helix of the Antennapedia Homeodomain translocates through biological membranes. J Chem. (1994) 269(14):10444–10450.
   Google Scholar
• ••Identification of the translocation domain of pAntp.
   Google Scholar
• DEROSSI D, CHASSAING G, PROCHIANTZ A: Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol. (1998) 8 (2) :84–87.
   PubMed Web of Science ®Google Scholar
• GIORELLO L, CLERICO L, PESCAROLO MP et al.: Inhibi-tion of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence. Cancer Res. (1998) 58 (16):3654–3659.
   PubMed Web of Science ®Google Scholar
• LINDGREN M, HALLBRINK M, PROCHIANTZ A, LANGEL U: Cell-penetrating peptides. Trends Pharmacol. ScL (2000) 21 (3):99–103.
   PubMed Web of Science ®Google Scholar
• HAWIGER J: Cellular import of functional peptides to block intracellular signaling. CUIT. Opin. Immunol. (1997) 9(2):189–194.
   PubMed Web of Science ®Google Scholar
• ••Discussions of the various classes of cell-penetratingpeptides and their applications [56].
   Google Scholar
• HAWIGER J: Noninvasive intracellular delivery of functional peptides and proteins. CUIT. Opin. Chem. Biol. (1999) 3(0:89–94.
   PubMedGoogle Scholar
• CHATELIN L, VOLOVITCH M, JOLIOT AH, PEREZ F, PROCHIANTZ A: Transcription factor hoxa-5 is taken up by cells in culture and conveyed to their nuclei. Mech. Dev. (1996) 55(2):111–117.
   PubMed Web of Science ®Google Scholar
• MAIZEL A, BENSAUDE O, PROCHIANTZ A, JOLIOT A: A short region of its homeodomain is necessary for engrailed nuclear export and secretion. Development (1999) 126(14)3183–3190.
   Google Scholar
• JOLIOT A, MAIZEL A, ROSENBERG D et al.: Identification of a signal sequence necessary for the unconventional secretion of engrailed homeoprotein. Cum Biol. (1998) 8 (15):856–863.
   PubMed Web of Science ®Google Scholar
• OESS S, HILDT E: Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens. Gene Ther. (2000) 7 (9) :750–758.
   PubMed Web of Science ®Google Scholar
• •Gene therapy utilising an HBV-derived peptide.
   Google Scholar
• POOGA M, HALLBRINK M, ZORKO M, LANGEL U: Cell penetration by transportan. FASEBJ (1998)12 (1) :67–77.
   PubMed Web of Science ®Google Scholar
• OEHLKE J, SCHELLER A, WIESNER B et al: Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non- endocytically. Biochim. Biophys. Acta. (1998) 1414(1-2):127–139.
   PubMed Web of Science ®Google Scholar
• POOGA M, SOOMETS U, HALLBRINK M et al.: Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nature Biotech. (1998) 16(9):857–861.
   PubMed Web of Science ®Google Scholar
• OH KJ, SENZEL L, COLLIER RJ, FINKELSTEIN A: Transloca-tion of the catalytic domain of diphtheria toxin across planar phospholipid bilayers by its own T domain. Proc. Natl. Acad. ScL USA (1999) 96(15):8467–8470.
   PubMed Web of Science ®Google Scholar
• LOREGIAN A, PAPINI E, SATIN B, MARSDEN HS, HIRST TR,PALU G: Intranuclear delivery of an antiviral peptide mediated by the B subunit of Escherichia coli heat-labile enterotoxin. Proc. Natl. Acad. ScL USA (1999) 96 (9):5221–5226.
   PubMed Web of Science ®Google Scholar
• BALLARD JD, COLLIER RJ, STARNBACH MN: Anthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo. Proc. Natl. Acad. ScL USA (1996) 93 (22) :12531–12534.
   PubMed Web of Science ®Google Scholar
• WESCHE J, ELLIOTT JL, FALNES PO, OLSNES S, COLLIER RJ: Characterization of membrane translocation by anthrax protective antigen. Biochemistry (1998) 37 (45):15737–15746.
   PubMed Web of Science ®Google Scholar
• SCHATZ G, DOBBERSTEIN B: Common principles of protein translocation across membranes. Science (1996) 271 (5255):1519–1526.
   PubMed Web of Science ®Google Scholar
• GORLICH D, MATTAJ IW: Nucleocytoplasmic transport. Science (1996) 271 (5255) :1513–1518.
   PubMed Web of Science ®Google Scholar
• OKAMOTO T, SCHLEGEL A, SCHERER PE, LISANTI MP: Caveolins, a family of scaffolding proteins for organizing `preassembled signaling complexes' at the plasma membrane. J. Biol. Chem. (1998) 273(105419–5422.
   Google Scholar
• FINK AL: Chaperone-mediated protein folding. Physiol Rev. (1999) 79(2):425–449.
   PubMed Web of Science ®Google Scholar
• EISENBERG D: How chaperones protect virgin proteins [comment]. Science (1999) 285 (54301021–1022.
   Google Scholar
• ELLIS RJ: Do molecular chaperones have to be proteins? Biochem. Biophys. Res. Commun. (1997) 238 (3):687–692.
   PubMed Web of Science ®Google Scholar
• BOGDANOV M, DOWHAN W: lipid-assisted protein folding. J Biol. Chem. (1999) 274(52):36827–36830.
   PubMed Web of Science ®Google Scholar
• •Review of initial findings on the potential chaperone-like activity of the lipid bilayer.
   Google Scholar
• COPELAND RA, JI H, HALFPENNY AJ et al: The structure of human acidic fibroblast growth factor and its interaction with heparin. Arch. Biochem. Biophys. (1991) 289 (1):53–61.
   PubMed Web of Science ®Google Scholar
• DABORA JM, SANYAL G, MIDDAUGH CR: Effect of polyanions on the refolding of human acidic fibroblast growth factor. J. Biol. Chem. (1991) 266 (35) 23637–23640.
   PubMed Web of Science ®Google Scholar
• RICHARDSON TP, TRINKAUS-RANDALL V, NUGENT MA:Regulation of basic fibroblast growth factor binding and activity by cell density and hepar an sulfate. j Biol. Chem. (1999) 274(19):13534–13540.
   PubMed Web of Science ®Google Scholar
• KUELTZO LA, O'HARE P, MIDDAUGH CR: Conforma-tional lability of herpes virus protein VP22. j Biol. Chem. (2000). (In Press).
   Google Scholar
• RUSNATI M, COLTRINI D, ORESTE P et al: Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation and size. J. Biol. Chem. (1997) 272(17):11313–11320.
   Google Scholar
• RUSNATI M, TULIPANO G, SPILLMANN D et al.: Multiple interactions of Hill-1 Tat protein with size-defined heparin oligosaccharides. J. Biol. Chem. (1999) 274(4028198–28205.
   Google Scholar
• RUSNATI M, TULIPANO G, URBINATI C et al: The basic domain in HIV-1 Tat protein as a target for polysulfo-nated heparin-mimicking extracellular Tat antago-nists. J Biol. Chem. (1998) 273(26):16027–16037.
   PubMed Web of Science ®Google Scholar
• ALBINI A, BENELLI R, PRESTA M et al.: HIV-tat protein is a hep arm-binding an gio gen ic growth factor. Oncogene (1996) 12(2):289–297.
   PubMed Web of Science ®Google Scholar
• PTITSYN OB: Molten globule and protein folding. Adv. Prot. Chem. (1995) 47:83–229.
   PubMedGoogle Scholar
• •Comprehensive review of molten globule states.
   Google Scholar
• BYCHKOVA VE, PAIN RH, PTITSYN OB: The 'molten globule' state is involved in the translocation of proteins across membranes? FEBS Lett. (1988) 238 (2):231–234.
   Google Scholar
• SKORKO-GLONEK J, LIPINSKA B, KRZEWSKI K, ZOLESE G, BERTOLI E, TANFANI F: HtrA heat shock protease interacts with phospholipid membranes and undergoes conformational changes. J Biol. Chem. (1997) 272(108974–8982.
   Google Scholar
• SHIN I, SILMAN I, WEINER LM: Interaction of partially unfolded forms of Torpedo acetylcholinesterase with liposomes. Protein Sci. (1996) 5(0:42–51.
   PubMedGoogle Scholar
• MEL SF, STROUD RM: Colicin Ia inserts into negatively charged membranes at low pHwith a tertiary but little secondary structural change. Biochemistry (1993) 32 (8):2082–2089.
   PubMed Web of Science ®Google Scholar
• VAN DER GOOT FG, GONZALEZ-MANAS JM, LAKEY JH, PATTUS F: A 'molten-globule' membrane-insertion intermediate of the pore-forming domain of colicin A. Nature (1991) 354:408–410.
   PubMed Web of Science ®Google Scholar
• MACH H, RYAN JA, BURKE CJ, VOLKIN DB, MIDDAUGH CR: Partially structured self-associating states of acidic fibroblast growth factor. Biochemistry (1 99 3) 32 (30):7703–7711.
   Google Scholar
• •Conformation dependence of FGF-1 lipid interactions.
   Google Scholar
• REN J, KACHEL K, KIM H, MALENBAUM SE, COLLIER RJ, LONDON E: Interaction of diphtheria toxin T domain with molten globule-like proteins and its implications for translocation. Science (1999) 284 (5416):955–957.
   PubMed Web of Science ®Google Scholar
• MACH H, MIDDAUGH CR: Interaction of partially structured states of acidic fibroblast growth factor with phospholipid membranes. Biochemistry (1995) 34(30:9913–9920.
   PubMedGoogle Scholar
• BERLOSE JP, CONVERT O, DEROSSI D, BRUNISSEN A, CHASSAING G: Conformational and associative behaviours of the third helix of antennapedia homeodomain in membrane-mimetic environments. Eur. j Biochem. (1996) 242 (2):372–386.
   PubMedGoogle Scholar
• FISCHER PM, ZHELEV NZ, WANG S, MELVILLE JE, FAHRAEUS R, LANE DP: Structure-activity relationship of truncated and substituted analogues of the intracel-lular delivery vector penetratin. Peptide Res. (2000) 55:163–172.
   Google Scholar
• ••Investigation of the effect of mutation on penetratininternalisation.
   Google Scholar
• KOLTOVER I, SALDITT T, RADLER JO, SAFINYA CR: An inverted hexagonal phase of cationic liposome-DNA complexes related to DNArelease and delivery. Science (1998) 281 (5373):78–81.
   PubMed Web of Science ®Google Scholar
• PEREIRA FB, VALPUESTA JM, BASANEZ G, GONI FM, NIEVA JL: Interbilayer lipid mixing induced by the human immunodeficiency virus type-1 fusion peptide on large unilamellar vesicles: the nature of the nonlamellar intermediates. Chem. Phys. Lipids. (1999) 103 (1-2):11–20.
   PubMed Web of Science ®Google Scholar
• PHOENIX DA, HARRIS F: Arnphiphilic CZ-helices and lipid interactions. In: Protein Targeting and Transloca-tion. Phoenix DA (Ed.), Princeton University Press, Princeton, USA (1998):19–36.
   Google Scholar
• ARUNKUMAR Al, KUMAR TK, YU C: Specificity of helix-induction by 2,2,2-trifluoroethanol in polypeptides. Int. J. Biol. Macromol. (1997) 21(3):223–230.
   PubMed Web of Science ®Google Scholar
• DU C, YAO S, ROJAS M, LIN YZ: Conformational and topological requirements of cell-permeable peptide function. J Pept. Res. (1998) 51(3):235–243.
   PubMedGoogle Scholar
• KUCHLER K: Unusual routes of protein secretion: the easy way out. Trends Cell Biol. (1993) 3:421–426.
   PubMedGoogle Scholar
• KUCHLER K, EGNER R: Unusual protein secretion and translocation pathways in yeast: implication of ABC transporters. In: Unusual Secretory Pathways: From Bacteria to Man. Kuchler K (Ed.), R.G. Landes Bioscience, Austin, TX, USA (1997):49–86.
   Google Scholar
• TERLECKY SR, DICE JF: Polypeptide import and degradation by isolated lysosomes. j Biol. Chem. (1993) 268(30:23490–23495.
   PubMedGoogle Scholar
• WRIGHT PE, DYSON HJ: Intrinsically unstructured proteins: re-assessing the protein structure- function paradigm. j Mol. Biol. (1999) 293(2):321–331.
   PubMed Web of Science ®Google Scholar
• •A look at the current view of unstructured proteins.
   Google Scholar
• TOROK Z, HORVATH I, GOLOUBINOFF P et al.: Evidence for a lipochaperonin: association of active protein-folding GroESL oligomers with lipids can stabilize membranes under heat shock conditions. Proc. Nati Acad. Sci. USA (1997) 94 (6):2192–2197.
   PubMed Web of Science ®Google Scholar
• GENGRINOVITCH S, BERMAN B, DAVID G, WITTE L, NEUFELD G, RON D: Glypican-1 is a VEGF165 binding p r o te o gly can that acts as an ex tr acellular chaperone for VEGF165. J. Biol. Chem. (1999) 274 (16) :10816–10822.
   PubMed Web of Science ®Google Scholar
• SCHUTZE-REDELMEIER MP, GOURNIER H, GARCIA-PONS F et al.: Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo. J. Immunol. (1996) 157(2)650–655.
   Google Scholar